HIV Reverse Transcriptase
- Name
- HIV Reverse Transcriptase
- Accession Number
- DBCAT001776
- Description
Not Available
- Drugs
Drug Drug Description Elvucitabine Investigated for use/treatment in hepatitis (viral, B) and HIV infection. Dexelvucitabine Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus. Dapivirine Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures. - Drugs & Drug Targets
Drug Target Type Elvucitabine Reverse transcriptase/RNaseH target Dexelvucitabine Reverse transcriptase/RNaseH target Dapivirine Gag-Pol polyprotein target